Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Alza in-line I.V. system

Executive Summary

The first Baxter product using the system will not be for "post-surgical pain," as reported in "The Pink Sheet" Oct. 29 (p. 16). Baxter has filed an ANDA but has not disclosed what drug is involved. In addition, the "one-time deduction" for the start-up of Alza's new Vacaville, Calif. manufacturing facility is the initial of two or three quarterly deductions of approximately the same amount. Alza retains an option to acquire Bio-Electro Systems until its stockholder's equity drop below $4 mil., not $6 mil. as was reported....Bristol-Myers Squibb's Pravachol: HMG-CoA reductase inhibitor pravastatin was studied at 40 mg QD (once a day) and 20 mg b.i.d., not four times a day ("The Pink Sheet", Oct. 29, p. 8).

You may also be interested in...

COVID-19 Flexibility For Telehealth Payments Should Be Made Permanent, Telemedicine Group Tells CMS

The American Telemedicine Association backed use of more telehealth providers and changes to remote monitoring reimbursements in comments to the US Medicare agency.

STADA Strengthens Specialty Partnership Role Via US Filing

STADA Strengthens Specialty Partnership Role Via US Filing

US Election 2020: Trump’s Sway Over Courts Expected To Linger

Textualist judges appointed by President Trump during his term may block a potential President Biden’s attempts to shift the government’s legal policies, experts tell Medtech Insight.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts